Dawn L. Hershman
#100,849
Most Influential Person Now
American oncologist
Dawn L. Hershman's AcademicInfluence.com Rankings
Dawn L. Hershmanmedical Degrees
Medical
#1399
World Rank
#1732
Historical Rank
#376
USA Rank
Oncology
#83
World Rank
#87
Historical Rank
#18
USA Rank
Download Badge
Medical
Dawn L. Hershman's Degrees
- Doctorate Medicine Columbia University
Why Is Dawn L. Hershman Influential?
(Suggest an Edit or Addition)According to Wikipedia, Dawn Luryn Hershman is an American oncologist. Since 2020, she has served as the American Cancer Society Professor of Medicine and Epidemiology at Columbia University. Early life and education Hershman was born to artists Lynn Hershman Leeson and George Leeson. She completed her undergraduate degree in psychology from the University of California, Los Angeles and earned her medical degree in 1994 from Albert Einstein College of Medicine. While completing her residency and fellowship at NewYork-Presbyterian Hospital, she was appointed chief resident from 1997 to 1998.
Dawn L. Hershman's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study (2020) (1264)
- Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. (2014) (910)
- Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer (2011) (683)
- Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. (2010) (680)
- Nationwide Trends in the Performance of Inpatient Hysterectomy in the United States (2013) (558)
- Robotically assisted vs laparoscopic hysterectomy among women with benign gynecologic disease. (2013) (462)
- Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group. (2009) (436)
- Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. (2007) (429)
- Doxorubicin, cardiac risk factors, and cardiac toxicity in elderly patients with diffuse B-cell non-Hodgkin's lymphoma. (2008) (341)
- Chemotherapy and cardiotoxicity in older breast cancer patients: a population-based study. (2005) (321)
- Racial disparities in treatment and survival among women with early-stage breast cancer. (2005) (300)
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update. (2020) (291)
- Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. (2011) (280)
- Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. (2007) (267)
- American Society of Clinical Oncology position statement on obesity and cancer. (2014) (235)
- Randomized exercise trial of aromatase inhibitor-induced arthralgia in breast cancer survivors. (2015) (232)
- Oncology Practice During the COVID-19 Pandemic. (2020) (219)
- Hormone receptor status and survival in a population‐based cohort of patients with breast carcinoma (2005) (218)
- Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. (2014) (214)
- Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation (2019) (213)
- Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline (2021) (210)
- Association between patient reported outcomes and quantitative sensory tests for measuring long-term neurotoxicity in breast cancer survivors treated with adjuvant paclitaxel chemotherapy (2011) (210)
- Prognostic significance of adenocarcinoma histology in women with cervical cancer. (2012) (209)
- Integrative Therapies During and After Breast Cancer Treatment: ASCO Endorsement of the SIO Clinical Practice Guideline. (2018) (198)
- Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy (2007) (198)
- Patient income level and cancer clinical trial participation. (2013) (193)
- Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents (2011) (186)
- Comparison of survival outcomes among cancer patients treated in and out of clinical trials. (2014) (185)
- Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial (2018) (179)
- Social networks, social support mechanisms, and quality of life after breast cancer diagnosis (2013) (175)
- Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer. (2012) (173)
- Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. (2013) (170)
- American society of clinical oncology position statement on obesity and cancer (2015) (170)
- Cost-Effectiveness of Preventive Strategies for Women with a BRCA1 or a BRCA2 Mutation (2006) (165)
- Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. (2006) (161)
- Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women (2006) (159)
- Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. (2006) (155)
- Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis. (2002) (155)
- High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. (2009) (150)
- Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. (2008) (145)
- Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials. (2016) (144)
- Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance. (2015) (141)
- Ethnic neutropenia and treatment delay in African American women undergoing chemotherapy for early-stage breast cancer. (2003) (136)
- Association between Plasma 25-Hydroxyvitamin D and Breast Cancer Risk (2009) (131)
- Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer (2006) (131)
- Comparative effectiveness research in oncology methodology: observational data. (2012) (130)
- Variations in the use of chemotherapy for elderly patients with advanced ovarian cancer: a population-based study. (2002) (125)
- Comparative effectiveness of minimally invasive and abdominal radical hysterectomy for cervical cancer. (2012) (119)
- Zoledronic acid prevents bone loss in premenopausal women undergoing adjuvant chemotherapy for early-stage breast cancer. (2008) (117)
- Effect of Surgical Volume on Outcomes for Laparoscopic Hysterectomy for Benign Indications (2012) (117)
- Treatment quality and outcomes of African American versus white breast cancer patients: retrospective analysis of Southwest Oncology studies S8814/S8897. (2009) (116)
- The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study (2010) (115)
- Observational study of the prevalence of febrile neutropenia in patients who received filgrastim or pegfilgrastim associated with 3-4 week chemotherapy regimens in community oncology practices. (2015) (112)
- Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines. (2019) (111)
- Association between Body Mass Index and Cancer Survival in a Pooled Analysis of 22 Clinical Trials (2016) (111)
- Safety and efficacy of neratinib (HKI-272) plus vinorelbine in the treatment of patients with ErbB2-positive metastatic breast cancer pretreated with anti-HER2 therapy. (2013) (108)
- Randomized controlled trial of a clinic-based survivorship intervention following adjuvant therapy in breast cancer survivors (2013) (107)
- Use of antioxidant supplements during breast cancer treatment: a comprehensive review (2009) (105)
- Effect of metformin vs placebo on and metabolic factors in NCIC CTG MA.32. (2015) (105)
- Comparative effectiveness of screening and prevention strategies among BRCA1/2-affected mutation carriers (2011) (102)
- Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study (2010) (101)
- Association of Patient Comorbid Conditions With Cancer Clinical Trial Participation (2019) (101)
- Treatment for Breast Cancer in Patients with Alzheimer's Disease (2005) (101)
- Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study. (2016) (101)
- Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy (2010) (100)
- Common psychosocial factors underlying breast cancer screening and breast cancer treatment adherence: a conceptual review and synthesis. (2007) (98)
- Surgeon characteristics and receipt of adjuvant radiotherapy in women with breast cancer. (2008) (98)
- Deviations from guideline-based therapy for febrile neutropenia in cancer patients and their effect on outcomes. (2013) (97)
- A pilot randomized controlled trial of a commercial diet and exercise weight loss program in minority breast cancer survivors (2012) (97)
- Complications Following Stereotactic Needle Biopsy of Intracranial Tumors. (2015) (95)
- Household net worth, racial disparities, and hormonal therapy adherence among women with early-stage breast cancer. (2015) (93)
- BMI, Lifestyle Factors and Taxane‐Induced Neuropathy in Breast Cancer Patients: The Pathways Study (2017) (92)
- Digital optical tomography system for dynamic breast imaging. (2011) (90)
- Feasibility and economic impact of same-day discharge for women who undergo laparoscopic hysterectomy. (2012) (90)
- Predictors of survival after hepatic resection among patients with colorectal liver metastasis (2007) (88)
- Incidence and predictors of bowel obstruction in elderly patients with stage IV colon cancer: a population-based cohort study. (2013) (88)
- National Cancer Institute-supported chemotherapy-induced peripheral neuropathy trials: outcomes and lessons (2016) (87)
- Racial Disparities in Utilization of Liver Transplantation for Hepatocellular Carcinoma in the United States, 1998–2002 (2008) (87)
- Geographic Distribution and Survival Outcomes for Rural Patients With Cancer Treated in Clinical Trials (2018) (87)
- Patterns of care and treatment outcomes for elderly women with cervical cancer (2012) (87)
- Effect of Regional Hospital Competition and Hospital Financial Status on the Use of Robotic-Assisted Surgery. (2016) (87)
- Dietary Supplement Use During Chemotherapy and Survival Outcomes of Patients With Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221). (2019) (86)
- The change from brand-name to generic aromatase inhibitors and hormone therapy adherence for early-stage breast cancer. (2014) (85)
- Radiation therapy, cardiac risk factors, and cardiac toxicity in early-stage breast cancer patients. (2007) (85)
- Effect of Radical Cytoreductive Surgery on Omission and Delay of Chemotherapy for Advanced-Stage Ovarian Cancer (2012) (85)
- An Economic Analysis of Robotically Assisted Hysterectomy (2014) (84)
- Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival (2008) (84)
- Failure to rescue as a source of variation in hospital mortality for ovarian cancer. (2012) (84)
- Ethnicity and persistent symptom burden in breast cancer survivors (2009) (84)
- Pilot study of acupuncture for the treatment of joint symptoms related to adjuvant aromatase inhibitor therapy in postmenopausal breast cancer patients (2007) (82)
- Uterine Pathology in Women Undergoing Minimally Invasive Hysterectomy Using Morcellation (2014) (82)
- Regional and racial disparities in breast cancer-specific mortality. (2006) (81)
- Perioperative Morbidity and Mortality of Patients With COVID-19 Who Undergo Urgent and Emergent Surgical Procedures (2020) (80)
- Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Patients With Metastatic Prostate Cancer. (2016) (79)
- Comparative Effectiveness of Minimally Invasive Hysterectomy for Endometrial Cancer. (2016) (78)
- Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. (2013) (78)
- Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer (2014) (77)
- Patterns of use and risks associated with erythropoiesis-stimulating agents among Medicare patients with cancer. (2009) (77)
- Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor–Negative Breast Cancer (2012) (76)
- Esophagectomy compared with chemoradiation for early stage esophageal cancer in the elderly (2009) (76)
- Perioperative Outcomes, Health Care Costs, and Survival After Robotic-assisted Versus Open Radical Cystectomy: A National Comparative Effectiveness Study. (2016) (76)
- Outcomes of tamoxifen chemoprevention for breast cancer in very high-risk women: a cost-effectiveness analysis. (2002) (76)
- Complementary and alternative medicine use among US cancer survivors (2016) (75)
- Defining the limits of radical cytoreductive surgery for ovarian cancer. (2011) (74)
- Phase I–II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo (2012) (74)
- Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer (2016) (73)
- Surgeon Characteristics and Use of Breast Conservation Surgery in Women With Early Stage Breast Cancer (2009) (72)
- Randomized Multicenter Placebo-Controlled Trial of Omega-3 Fatty Acids for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain: SWOG S0927. (2015) (72)
- “When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials (2020) (71)
- The effect of exercise on body composition and bone mineral density in breast cancer survivors taking aromatase inhibitors (2017) (71)
- Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer (2011) (70)
- Prevention with tamoxifen or other hormones versus prophylactic surgery in BRCA1/2-positive women: a decision analysis. (2000) (70)
- Physical activity before, during and after chemotherapy for high-risk breast cancer: relationships with survival. (2020) (70)
- Trends in Surgical Mesh Use for Pelvic Organ Prolapse From 2000 to 2010 (2012) (68)
- Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221) (2011) (67)
- Phase II Trial of Tipifarnib plus Neoadjuvant Doxorubicin-Cyclophosphamide in Patients with Clinical Stage IIB-IIIC Breast Cancer (2009) (67)
- Uterine pathology in women undergoing minimally invasive hysterectomy using morcellation. (2014) (66)
- Diabetes, Body Mass Index, and Outcomes in Hepatocellular Carcinoma Patients Undergoing Liver Transplantation (2012) (66)
- Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design (2017) (66)
- Targeted inhibition of farnesyltransferase in locally advanced breast cancer: a phase I and II trial of tipifarnib plus dose-dense doxorubicin and cyclophosphamide. (2006) (66)
- Association Between Geographic Access to Cancer Care and Receipt of Radiation Therapy for Rectal Cancer. (2016) (65)
- Use of Electric Power Morcellation and Prevalence of Underlying Cancer in Women Who Undergo Myomectomy. (2015) (65)
- Trends in Relative Survival for Ovarian Cancer From 1975 to 2011 (2015) (65)
- Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk (2015) (65)
- Presurgical Trial of Metformin in Overweight and Obese Patients with Newly Diagnosed Breast Cancer (2014) (63)
- Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials (2020) (63)
- Racial disparities in treatment and survival of male breast cancer. (2007) (62)
- The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme (2010) (62)
- NCI Clinical Trials Planning Meeting for prevention and treatment of chemotherapy-induced peripheral neuropathy. (2019) (61)
- Comparative Outcomes of Elderly Stage I Lung Cancer Patients Treated with Segmentectomy via Video-Assisted Thoracoscopic Surgery versus Open Resection (2014) (61)
- Within‐stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer (2007) (61)
- Cardiac effects of anticancer therapy in the elderly. (2014) (60)
- The modified frailty index and 30-day adverse events in oncologic neurosurgery (2017) (60)
- The commercialization of robotic surgery: unsubstantiated marketing of gynecologic surgery by hospitals. (2012) (59)
- Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL) (2012) (59)
- Hepatitis B Virus Screening and Management for Patients With Cancer Prior to Therapy: ASCO Provisional Clinical Opinion Update. (2020) (59)
- Nonadherence to Medications for Chronic Conditions and Nonadherence to Adjuvant Hormonal Therapy in Women With Breast Cancer. (2016) (58)
- Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. (2016) (58)
- Prevention of bone loss by zoledronic acid in premenopausal women undergoing adjuvant chemotherapy persist up to one year following discontinuing treatment. (2010) (57)
- Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography (2013) (57)
- Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202. (2017) (57)
- Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices (2019) (57)
- Drug Utilization in the Old Old and How it Relates to Self‐Perceived Health and All‐Cause Mortality: Results from the Bronx Aging Study (1995) (57)
- Dietary modifications, weight loss, and changes in metabolic markers affect global DNA methylation in Hispanic, African American, and Afro-Caribbean breast cancer survivors. (2015) (56)
- Anthracycline cardiotoxicity after breast cancer treatment. (2009) (56)
- Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer. (2004) (56)
- Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline Summary. (2014) (55)
- Long-term mortality among women with epithelial ovarian cancer. (2015) (55)
- Racial and insurance disparities in the receipt of transplant among patients with hepatocellular carcinoma (2010) (55)
- Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma. (2004) (54)
- Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome. (2013) (54)
- Influence of Surgical Volume on Outcome for Laparoscopic Hysterectomy for Endometrial Cancer (2012) (54)
- Comparative Effectiveness of Cancer Control and Survival after Robot‐Assisted versus Open Radical Prostatectomy (2017) (52)
- Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715) (2018) (52)
- Natural history and outcome of neuroendocrine carcinoma of the cervix. (2016) (52)
- Magnitude of risk for nodal metastasis associated with lymphvascular space invasion for endometrial cancer. (2016) (51)
- Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL) (2016) (51)
- Duffy (Fy), DARC, and neutropenia among women from the United States, Europe and the Caribbean (2008) (51)
- Exercise adherence in a randomized trial of exercise on aromatase inhibitor arthralgias in breast cancer survivors: the Hormones and Physical Exercise (HOPE) study (2016) (51)
- Patterns of use of hemostatic agents in patients undergoing major surgery. (2014) (50)
- A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer (2014) (49)
- Association of Cardiovascular Risk Factors With Cardiac Events and Survival Outcomes Among Patients With Breast Cancer Enrolled in SWOG Clinical Trials. (2018) (49)
- Psychosocial Influences on Suboptimal Adjuvant Breast Cancer Treatment Adherence Among African American Women: Implications for Education and Intervention (2008) (49)
- Recommendations for Obesity Clinical Trials in Cancer Survivors: American Society of Clinical Oncology Statement. (2015) (48)
- Contraindicated use of bevacizumab and toxicity in elderly patients with cancer. (2013) (47)
- Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literature. (2005) (47)
- National Trends in Prostate Biopsy and Radical Prostatectomy Volumes Following the US Preventive Services Task Force Guidelines Against Prostate-Specific Antigen Screening (2017) (46)
- Barriers to minority participation in breast carcinoma prevention trials (2005) (46)
- Association of Hospital Volume and Quality of Care With Survival for Ovarian Cancer. (2017) (46)
- Adjuvant intravesical bacillus calmette-guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer. (2013) (45)
- Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial. (2014) (45)
- Utilization and Outcomes of Ovarian Conservation in Premenopausal Women With Endometrial Cancer (2016) (45)
- Influence of treatment center and hospital volume on survival for locally advanced cervical cancer. (2015) (45)
- The role for adjuvant radiotherapy in the treatment of hemangiopericytoma: a Surveillance, Epidemiology, and End Results analysis. (2014) (45)
- Population-level trends in relative survival for cervical cancer. (2015) (43)
- Outcomes of Hysterectomy Performed by Very Low-Volume Surgeons. (2018) (43)
- The Scientific Impact of Positive and Negative Phase 3 Cancer Clinical Trials. (2016) (43)
- Toxicity burden score: a novel approach to summarize multiple toxic effects. (2012) (43)
- Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004–2007 (2012) (42)
- Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. (2015) (42)
- Trends in Use and Outcomes of Women Undergoing Hysterectomy With Electric Power Morcellation. (2016) (41)
- Phase II study of glucosamine with chondroitin on aromatase inhibitor-associated joint symptoms in women with breast cancer (2013) (40)
- Symptoms: Chemotherapy-Induced Peripheral Neuropathy. (2015) (40)
- Racial/ethnic and socioeconomic differences in short-term breast cancer survival among women in an integrated health system. (2015) (40)
- Access to Conservative Surgical Therapy for Adolescents With Benign Ovarian Masses (2012) (39)
- Treatment of hot flushes in breast and prostate cancer (2005) (39)
- Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies (2020) (38)
- Characterizing 18 Years of the Death With Dignity Act in Oregon (2017) (38)
- Serum Adiponectin Is Associated with Worsened Overall Survival in a Prospective Cohort of Hepatocellular Carcinoma Patients (2014) (38)
- Risk stratification and outcomes of women undergoing surgery for ovarian cancer. (2015) (37)
- ¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors. (2015) (37)
- Randomized Trial of Text Messaging to Reduce Early Discontinuation of Adjuvant Aromatase Inhibitor Therapy in Women With Early-Stage Breast Cancer: SWOG S1105. (2020) (37)
- Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study. (2012) (37)
- Quality and Outcomes of Treatment of Hypercalcemia of Malignancy (2015) (36)
- Bowel obstruction in elderly ovarian cancer patients: a population-based study. (2013) (36)
- Variation in Ovarian Conservation in Women Undergoing Hysterectomy for Benign Indications (2013) (36)
- Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial. (2016) (36)
- Use of Guideline-Based Antibiotic Prophylaxis in Women Undergoing Gynecologic Surgery (2013) (36)
- Use and Misuse of Opioids After Gynecologic Surgical Procedures. (2019) (35)
- Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study (2013) (35)
- Survivorship care plans and adherence to lifestyle recommendations among breast cancer survivors (2016) (35)
- Effect of Metformin vs Placebo on Invasive Disease-Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial. (2022) (35)
- Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials (2021) (34)
- Outcomes and diffusion of doxorubicin‐based chemotherapy among elderly patients with aggressive non‐Hodgkin lymphoma (2006) (34)
- Disparities and challenges in adherence to oral antineoplastic agents. (2013) (34)
- Influence of private practice setting and physician characteristics on the use of breast cancer adjuvant chemotherapy for elderly women (2009) (34)
- Disparities in the management of ectopic pregnancy (2017) (34)
- Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307. (2019) (34)
- Management and Outcomes of Bowel Obstruction in Patients with Stage IV Colon Cancer: A Population-Based Cohort Study (2013) (33)
- Cracking open window of opportunity trials. (2012) (33)
- How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? (2017) (33)
- Dynamic Diffuse Optical Tomography for Monitoring Neoadjuvant Chemotherapy in Patients with Breast Cancer. (2018) (33)
- Breast Cancer Chemoprevention among High‐risk Women and those with Ductal Carcinoma In Situ (2015) (33)
- Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer. (2012) (33)
- Factors Associated With 30-Day Hospital Readmission After Hysterectomy (2015) (32)
- Traumatic stress symptoms and breast cancer: the role of childhood abuse. (2010) (31)
- Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study (2014) (31)
- Underuse of BRCA testing in patients with breast and ovarian cancer. (2016) (31)
- FOLFOX and FOLFIRI Use in Stage IV Colon Cancer: Analysis of SEER-Medicare Data. (2019) (31)
- Barriers to Recruitment and Adherence in a Randomized Controlled Diet and Exercise Weight Loss Intervention Among Minority Breast Cancer Survivors (2017) (31)
- Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials (2022) (30)
- Incidence, cost, and mortality associated with hospital-acquired conditions after resection of cranial neoplasms. (2014) (30)
- Neutropenia in 6 ethnic groups from the Caribbean and the U.S. (2008) (30)
- Trends in Medical Aid in Dying in Oregon and Washington (2019) (30)
- Cost of Care for the Initial Management of Ovarian Cancer. (2017) (29)
- Influence of Lymphadenectomy on Survival for Early-Stage Endometrial Cancer (2016) (29)
- Phase II trial of the farnesyltransferase inhibitor tipifarnib plus fulvestrant in hormone receptor-positive metastatic breast cancer: New York Cancer Consortium Trial P6205. (2009) (29)
- Germline genetic variants in ABCB1, ABCC1, and ALDH1A1 and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer (2013) (29)
- Prevalence and predictors of antioxidant supplement use during breast cancer treatment (2009) (29)
- Nationwide practice patterns for the use of venous thromboembolism prophylaxis among men undergoing radical prostatectomy (2014) (28)
- Trends in Use and Survival Associated With Fertility-Sparing Trachelectomy for Young Women With Early-Stage Cervical Cancer. (2018) (28)
- ¡Cocinar Para Su Salud!: Randomized Controlled Trial of a Culturally Based Dietary Intervention among Hispanic Breast Cancer Survivors. (2015) (28)
- Supplement use during an intergroup clinical trial for breast cancer (S0221) (2013) (28)
- Long-term Diet and Biomarker Changes after a Short-term Intervention among Hispanic Breast Cancer Survivors: The ¡Cocinar Para Su Salud! Randomized Controlled Trial (2016) (27)
- Failure to rescue after major gynecologic surgery. (2013) (27)
- Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927) (2018) (27)
- Development and validation of a risk-calculator for adverse perioperative outcomes for women with ovarian cancer. (2018) (27)
- The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ. (2015) (27)
- A New Framework for Patient Engagement in Cancer Clinical Trials Cooperative Group Studies (2018) (27)
- Endocrine‐related quality of life in a randomized trial of exercise on aromatase inhibitor–induced arthralgias in breast cancer survivors (2019) (27)
- Impact of Socioeconomic Status on Extent of Lymph Node Dissection for Colon Cancer (2010) (26)
- Breast cancer-related preferences among women with and without BRCA mutations (2009) (26)
- The Breast Cancer Quality of Care Study (BQUAL): A Multi‐Center Study to Determine Causes for Noncompliance with Breast Cancer Adjuvant Therapy (2012) (26)
- Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City (2020) (26)
- Nonadherence to Oral Medications for Chronic Conditions in Breast Cancer Survivors. (2016) (25)
- Obesity and Microvascular Invasion in Hepatocellular Carcinoma (2010) (25)
- Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system (2018) (25)
- ¡Cocinar Para Su Salud! Development of a Culturally Based Nutrition Education Curriculum for Hispanic Breast Cancer Survivors Using a Theory-Driven Procedural Model (2017) (25)
- Use and Costs of Disease Monitoring in Women With Metastatic Breast Cancer. (2016) (25)
- Randomized phase II trial of fulvestrant alone or in combination with bortezomib in hormone receptor-positive metastatic breast cancer resistant to aromatase inhibitors: a New York Cancer Consortium trial (2015) (24)
- Population‐based assessment of determining predictors for quality of prostate cancer surveillance (2015) (24)
- High versus low-dose rate brachytherapy for cervical cancer. (2015) (24)
- Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study (2017) (24)
- Utilization and Toxicity of Alternative Delivery Methods of Adjuvant Chemotherapy for Ovarian Cancer (2016) (24)
- Utility of radiation therapy for early-stage uterine papillary serous carcinoma. (2017) (24)
- Uptake and Patterns of Use of Gemcitabine for Metastatic Pancreatic Cancer: A Population-Based Study (2013) (23)
- All‐cause mortality in young women with endometrial cancer receiving progesterone therapy (2017) (23)
- Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology (2015) (23)
- Patterns and outcomes of chemotherapy for elderly patients with stage II ovarian cancer: a population-based study. (2004) (23)
- Care Delivery Impact of the COVID-19 Pandemic on Breast Cancer Care. (2021) (23)
- Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings (2020) (23)
- Trends in use and safety of image-guided transthoracic needle biopsies in patients with cancer. (2015) (23)
- Impact of primary prophylaxis on febrile neutropenia within community practices in the US (2009) (22)
- Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer (2017) (22)
- Changes in Surgical Volume and Outcomes Over Time for Women Undergoing Hysterectomy for Endometrial Cancer. (2018) (22)
- Uptake and outcomes of intensity-modulated radiation therapy for uterine cancer. (2013) (22)
- Safety and tolerance of radical hysterectomy for cervical cancer in the elderly. (2014) (22)
- Impact of Quality of Care on Racial Disparities in Survival for Endometrial Cancer. (2020) (22)
- Using Medicare Claims to Examine Long-term Prostate Cancer Risk of Finasteride in the Prostate Cancer Prevention Trial (2018) (21)
- The diffusion of docetaxel in patients with metastatic prostate cancer. (2015) (21)
- Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm (2017) (21)
- Racial disparities in young women with endometrial cancer. (2018) (21)
- Economic and Survival Implications of Use of Electric Power Morcellation for Hysterectomy for Presumed Benign Gynecologic Disease. (2015) (21)
- Utilization of sentinel lymph node biopsy for uterine cancer (2017) (21)
- Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer. (2011) (20)
- Phase I–II study of the farnesyl transferase inhibitor tipifarnib plus sequential weekly paclitaxel and doxorubicin–cyclophosphamide in HER2/neu-negative inflammatory carcinoma and non-inflammatory estrogen receptor-positive breast carcinoma (2013) (20)
- Phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: SWOG/Alliance/ECOG-ACRIN/NCIC Clinical Trials Group/NRG Oncology study S0307. (2015) (20)
- Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci (2018) (20)
- Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical Trials. (2016) (20)
- Use of adjuvant 5-fluorouracil and radiation therapy after gastric cancer resection among the elderly and impact on survival. (2010) (20)
- Prescription of extended-duration thromboprophylaxis after high-risk, abdominopelvic cancer surgery. (2016) (19)
- A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance (2020) (19)
- Use and benefits of laparoscopic hysterectomy for stage I endometrial cancer among medicare beneficiaries. (2012) (19)
- Racial disparities in the use of palliative therapy for ureteral obstruction among elderly patients with advanced prostate cancer (2013) (19)
- Association between survival time with metastatic breast cancer and aggressive end-of-life care (2017) (18)
- Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016 (2020) (18)
- Comparative Effectiveness of Robotically Assisted Compared With Laparoscopic Adnexal Surgery for Benign Gynecologic Disease (2014) (18)
- Association of National Cancer Institute–Sponsored Clinical Trial Network Group Studies With Guideline Care and New Drug Indications (2019) (18)
- Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients (2020) (18)
- Use and duration of chemotherapy and its impact on survival in early-stage ovarian cancer. (2014) (18)
- Relationship between surgical oncologic outcomes and publically reported hospital quality and satisfaction measures. (2015) (18)
- Association of Osteonecrosis of the Jaw With Zoledronic Acid Treatment for Bone Metastases in Patients With Cancer. (2020) (17)
- Radiation Duration in Women with Cervical Cancer Treated with Primary Chemoradiation: A Population-Based Analysis (2016) (17)
- Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic (2021) (17)
- Scalp Cooling to Prevent Chemotherapy-Induced Alopecia: The Time Has Come. (2017) (17)
- Quality of Perioperative Venous Thromboembolism Prophylaxis in Gynecologic Surgery (2011) (17)
- Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up (2020) (17)
- Abstract S3-03: Randomized trial of exercise vs. usual care on aromatase inhibitor-associated arthralgias in women with breast cancer: The hormones and physical exercise (HOPE) study (2013) (17)
- Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study (2022) (17)
- National Trends in Extended Procedures for Ovarian Cancer Debulking Surgery (2017) (16)
- Sticking to It: Improving Outcomes by Increasing Adherence. (2016) (16)
- Effects of the US Food and Drug Administration Boxed Warning of Erythropoietin-Stimulating Agents on Utilization and Adverse Outcome. (2017) (16)
- Safety and Efficacy of Neratinib (HKI-272) in Combination with Paclitaxel in ErbB2+ Metastatic Breast Cancer. (2009) (16)
- A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL) (2016) (16)
- Barriers and Facilitators to Recruitment to a Culturally Based Dietary Intervention Among Urban Hispanic Breast Cancer Survivors (2015) (16)
- Trends in Hospital Volume and Patterns of Referral for Women With Gynecologic Cancers (2013) (15)
- Symptoms: Aromatase Inhibitor Induced Arthralgias. (2015) (15)
- Using machine learning to create prognostic systems for endometrial cancer. (2020) (15)
- Serum Tumor Marker Use in Patients With Advanced Solid Tumors. (2016) (15)
- Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study. (2010) (15)
- Patterns of Specialty-Based Referral and Perioperative Outcomes for Women With Endometrial Cancer Undergoing Hysterectomy. (2017) (15)
- Phase 1 Study of Erlotinib and Metformin in Metastatic Triple-Negative Breast Cancer. (2020) (15)
- Guideline concordant care for prevention of acute chemotherapy-induced nausea and vomiting in children, adolescents, and young adults (2020) (14)
- Association between body mass index and response to duloxetine for aromatase inhibitor‐associated musculoskeletal symptoms in SWOG S1202 (2019) (14)
- Axillary evaluation and lymphedema in women with ductal carcinoma in situ (2016) (14)
- Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer (2020) (14)
- Failure to Rescue and Mortality Following Resection of Intracranial Neoplasms (2018) (14)
- Quality of Postoperative Venous Thromboembolism Prophylaxis in Neuro-oncologic Surgery (2016) (14)
- Breast biopsy and race/ethnicity among women without breast cancer. (2006) (14)
- Getting a grip on aromatase inhibitor-associated arthralgias. (2008) (14)
- Association Between Overall Survival and the Tendency for Cancer Programs to Administer Neoadjuvant Chemotherapy for Patients With Advanced Ovarian Cancer. (2021) (14)
- Bone Health History in Breast Cancer Patients on Aromatase Inhibitors (2014) (14)
- Safety and efficacy of neratinib (HKI-272) in combination with paclitaxel in patients with solid tumors. (2009) (14)
- Clinical decision support for therapeutic decision-making in cancer: A systematic review (2019) (14)
- Trends in end‐of‐life care and health care spending in women with uterine cancer (2017) (14)
- Patterns of seizure prophylaxis after oncologic neurosurgery (2019) (13)
- Characteristics associated with prolonged length of stay after hysterectomy for benign gynecologic conditions (2018) (13)
- Increased Expression of Tumor Proliferation Genes in Hispanic Women with Early-Stage Breast Cancer (2014) (13)
- SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery. (2014) (13)
- Prognostic Significance of Mucinous Differentiation of Endometrioid Adenocarcinoma of the Endometrium (2013) (13)
- American Society of Clinical Oncology Summit on Addressing Obesity Through Multidisciplinary Provider Collaboration: Key Findings and Recommendations for Action (2017) (13)
- A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions. (2013) (13)
- Utilization and Outcomes of Sentinel Lymph Node Biopsy for Vulvar Cancer (2016) (13)
- National Cancer Institute Breast Cancer Steering Committee Working Group Report on Meaningful and Appropriate End Points for Clinical Trials in Metastatic Breast Cancer. (2018) (13)
- Prevention of bone loss after withdrawal of tamoxifen. (2008) (13)
- Patterns of care for locally advanced vulvar cancer. (2013) (12)
- A stakeholder-informed randomized, controlled comparative effectiveness study of an order prescribing intervention to improve colony stimulating factor use for cancer patients receiving myelosuppressive chemotherapy: the TrACER study. (2017) (12)
- Perfecting breast-cancer treatment--incremental gains and musculoskeletal pains. (2015) (12)
- Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce Aromatase Inhibitor-related Joint Symptoms in Breast Cancer Patients. (2015) (12)
- Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers (2018) (12)
- Adherence to treatment recommendations and outcomes for women with ovarian cancer at first recurrence. (2017) (12)
- Phase I/II Trial of Ruxolitinib in Combination with Trastuzumab in Metastatic HER2 Positive Breast Cancer (2014) (12)
- Utilization and Safety of Sodium Hyaluronate-Carboxymethylcellulose Adhesion Barrier (2013) (12)
- Author Contributions Conception and design: All authors Collection and assembly of data: All authors Data analysis and interpretation: All authors Manuscript writing: All authors Final approval of manuscript: All authors (2014) (12)
- Diffuse optical tomography changes correlate with residual cancer burden after neoadjuvant chemotherapy in breast cancer patients (2017) (12)
- Erythropoiesis-stimulating agent use after changes in medicare reimbursement policies. (2014) (11)
- Effect of Minimum-Volume Standards on Patient Outcomes and Surgical Practice Patterns for Hysterectomy. (2018) (11)
- Trends in Sentinel Lymph Node Mapping and Adjuvant Therapy in Endometrial Carcinoma (2018) (11)
- A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer (2018) (11)
- Effects of adjuvant exemestane versus anastrozole on bone mineral density: Two-year results of the NCIC CTG MA.27 bone companion study. (2011) (11)
- Less-radical Surgery for Early Stage Cervical Cancer: A Systematic Review. (2020) (11)
- Safety of Same Day Discharge for Minimally Invasive Hysterectomy for Endometrial Cancer. (2019) (11)
- Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial (2021) (11)
- Uptake and Outcomes of Sentinel Lymph Node Mapping in Women With Atypical Endometrial Hyperplasia. (2021) (11)
- Characteristics and outcomes of patients with breast cancer diagnosed with SARS-Cov-2 infection at an academic center in New York City. (2020) (11)
- Patients' Perceptions of Physician-Patient Discussions and Adverse Events with Cancer Therapy (2008) (11)
- Safety, Utilization, and Cost of Image-Guided Percutaneous Liver Biopsy Among Cancer Patients (2016) (10)
- Akt Inhibition Is Associated With Favorable Immune Profile Changes Within the Tumor Microenvironment of Hormone Receptor Positive, HER2 Negative Breast Cancer (2020) (10)
- Smoking and hepatocellular carcinoma mortality. (2012) (10)
- Use and Misuse of Opioids After Endocrine Surgery Operations (2020) (10)
- Utilization of ovarian transposition for fertility preservation among young women with pelvic malignancies who undergo radiotherapy (2018) (10)
- Neuroendocrine carcinoma of the endometrium: Disease course, treatment, and outcomes. (2019) (10)
- Effects of metformin versus placebo on vitamin B12 metabolism in non-diabetic breast cancer patients in CCTG MA.32 (2017) (9)
- Cost of Care for the Initial Management of Cervical Cancer in Women with Commercial Insurance. (2020) (9)
- Clinical Usefulness of Bright White Light Therapy for Depressive Symptoms in Cancer Survivors: Results from a Series of Personalized (N-of-1) Trials (2019) (9)
- A Pilot Study of Interpersonal Psychotherapy for Depressed Women with Breast Cancer. (2014) (9)
- Impact of hospital volume on racial disparities and outcomes for endometrial cancer. (2018) (9)
- Sequencing of therapy in women with stage III endometrial carcinoma receiving adjuvant combination chemotherapy and radiation. (2019) (9)
- Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data. (2015) (9)
- Trends in Use and Effect on Survival of Simple Hysterectomy for Early-Stage Cervical Cancer. (2019) (9)
- Management of Chemotherapy-Induced Peripheral Neuropathy (2015) (9)
- Proteomic modulation in breast tumors after metformin exposure: results from a “window of opportunity” trial (2017) (9)
- Association between nonadherence to cardiovascular risk factor medications after breast cancer diagnosis and incidence of cardiac events (2020) (9)
- A phase III randomized trial of metformin versus placebo on recurrence and survival in early-stage breast cancer (BC) (NCIC Clinical Trials Group MA.32). (2011) (9)
- Chemotherapy, Radiation, or Combination Therapy for Stage III Uterine Cancer. (2019) (9)
- Association of New Perioperative Benzodiazepine Use With Persistent Benzodiazepine Use (2021) (9)
- The effect of guideline-concordant care in mitigating insurance status disparities in cervical cancer. (2020) (9)
- Uptake of oxaliplatin and bevacizumab for treatment of node-positive and metastatic colon cancer. (2012) (9)
- Perioperative outcomes, health care costs and survival after robotic-assisted versus open radical cystectomy: A national comparative effectiveness study (2016) (9)
- Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014 (2021) (9)
- Identifying Severe Adverse Event Clusters Using the National Cancer Institute's Common Terminology Criteria for Adverse Events. (2016) (9)
- Use of a urine anastrozole assay to determine treatment discontinuation among women with hormone-sensitive breast cancer: a pilot study. (2012) (9)
- Anthracycline cardiotoxicity: one size does not fit all! (2008) (8)
- Phase I-II study of the histone deacetylase inhibitor (HDACi) vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer (MBC): New York Cancer Consortium trial P7703. (2009) (8)
- Understanding Breast Cancer Knowledge and Barriers to Treatment Adherence: A Qualitative Study Among Breast Cancer Survivors (2017) (8)
- Utilization and Outcomes of Chemotherapy in Women With Intermediate-Risk, Early-Stage Ovarian Cancer (2016) (8)
- Network-based assessment of HDAC6 activity is highly predictive of pre-clinical and clinical responses to the HDAC6 inhibitor ricolinostat (2020) (8)
- Use of Fertility Preservation Services in Female Reproductive-Aged Cancer Patients. (2019) (8)
- Factors Associated With Cancer Treatment Delay Among Patients Diagnosed With COVID-19 (2022) (8)
- Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer. (2011) (8)
- Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients. (2018) (8)
- Obesity-associated Breast Inflammation among Hispanic/Latina Breast Cancer Patients (2018) (8)
- Use and impact of herpes zoster prophylaxis in myeloma patients treated with proteasome inhibitors (2018) (8)
- Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study (2022) (8)
- The effect of metformin vs placebo on sex hormones in CCTG MA.32. (2020) (8)
- Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer (2004) (8)
- Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (SWOG S0812) (2019) (8)
- Use of Bisphosphonates in Elderly Patients With Newly Diagnosed Multiple Myeloma. (2019) (8)
- Cost-Effectiveness Analysis of Biomarker-Guided Treatment for Metastatic Gastric Cancer in the Second-Line Setting (2020) (8)
- The Effect of Metformin vs Placebo on Sex Hormones in Canadian Cancer Trials Group MA.32. (2021) (8)
- Phase II study of propranolol feasibility with neoadjuvant chemotherapy in patients with newly diagnosed breast cancer (2021) (8)
- Quality of Care, Including Survivorship Care Plans. (2015) (8)
- Extent of Exclusions for Chronic Conditions in Breast Cancer Trials. (2018) (7)
- Diffuse optical tomography of the breast: a potential modifiable biomarker of breast cancer risk with neoadjuvant chemotherapy. (2019) (7)
- Effect of Regionalization of Endometrial Cancer Care on Site of Care and Patient Travel. (2019) (7)
- Regional Market Competition and the Use of Immediate Breast Reconstruction After Mastectomy (2018) (7)
- Quality of Care and Outcomes of Patients With Gynecologic Malignancies Treated at Safety-Net Hospitals (2019) (7)
- Utilization of gynecologic services in women with breast cancer receiving hormonal therapy (2017) (7)
- Sex differences in adverse event reporting in SWOG chemotherapy, biologic/immunotherapy, and targeted agent cancer clinical trials. (2019) (7)
- Effect of Patient Socioeconomic Status and Body Mass Index on the Quality of Breast Cancer Adjuvant Chemotherapy (2007) (7)
- Uptake and outcomes of sentinel lymph node mapping in women undergoing minimally invasive surgery for endometrial cancer (2021) (7)
- Osteonecrosis of the jaw in patients with cancer receiving zoledronic acid for bone metastases: SWOG S0702, NCT00874211. (2019) (7)
- Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer (2014) (7)
- Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105. (2019) (7)
- ¡Mi Vida Saludable! A randomized, controlled, 2 × 2 factorial trial of a diet and physical activity intervention among Latina breast cancer survivors: Study design and methods. (2021) (7)
- Investigator Use of Social Media for Recruitment of Patients for Cancer Clinical Trials (2020) (7)
- Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients. (2020) (7)
- Cost-Effectiveness Analysis of Hepatitis B Virus Screening and Management in Patients With Hematologic or Solid Malignancies Anticipating Immunosuppressive Cancer Therapy. (2019) (7)
- Overuse of external beam radiotherapy for stage I endometrial cancer. (2016) (7)
- Travel distance, hospital volume and their association with ovarian cancer short- and long-term outcomes. (2020) (7)
- Validation of toxicity burden score for use in phase I clinical trials. (2016) (6)
- Temporal Trends and Practice Patterns in the Urology Work Force between Low and High Density Population Areas (2017) (6)
- The Breast Cancer Weight Loss (BWEL) trial: Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early-stage breast cancer (Alliance A011401). (2018) (6)
- Factors Associated with Multidisciplinary Consultations in Patients with Early Stage Breast Cancer (2019) (6)
- Effect of metformin versus placebo on weight and metabolic factors in initial patients enrolled onto NCIC CTG MA.32, a multicenter adjuvant randomized controlled trial in early-stage breast cancer (BC). (2013) (6)
- Adherence to colonoscopy at 1 year following resection of localized colon cancer: a retrospective cohort study (2018) (6)
- Insurance-Associated Disparities in Opioid Use and Misuse Among Patients Undergoing Gynecologic Surgery for Benign Indications. (2020) (6)
- Adolescent and young adult enrollment to a National Cancer Institute–sponsored National Clinical Trials Network Research Group over 25 years (2021) (6)
- Potential Consequences of Minimum-Volume Standards for Hospitals Treating Women With Ovarian Cancer. (2019) (6)
- Trends in Use and Effect on Survival of Simple Hysterectomy for Early-Stage Cervical Cancer. (2019) (6)
- Chemotherapy-induced peripheral neuropathy: ice, compression, both, or neither? (2020) (6)
- Effect of early discontinuation and nonadherence to adjuvant hormone therapy on mortality in women with breast cancer. (2010) (6)
- Food environments are relevant to recruitment and adherence in dietary modification trials. (2015) (6)
- Chemotherapy Use in Elderly Patients with Soft Tissue Sarcoma: A Population-based Study (2013) (6)
- Disparities in Access to High-Volume Surgeons Within High-Volume Hospitals for Hysterectomy. (2021) (6)
- Use of Partial Nephrectomy after Acquisition of a Surgical Robot: A Population Based Study (2016) (6)
- Survival by Hispanic ethnicity among patients with cancer participating in SWOG clinical trials (2018) (6)
- Nationwide Estimates of Annual Inpatient and Outpatient Hysterectomies Performed in the United States. (2022) (6)
- Metastatic epidural spinal cord compression among elderly patients with advanced prostate cancer (2014) (6)
- S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients. (2022) (5)
- Abstract P3-14-04: Efficacy and Safety of Neratinib (HKI-272) in Combination with Paclitaxel in Her2+ Metastatic Breast Cancer (2010) (5)
- Association Between Hospital Financial Distress and Immediate Breast Reconstruction Surgery After Mastectomy Among Women With Ductal Carcinoma In Situ (2017) (5)
- Patient Reported Outcomes and Long-Term Non-Adherence to Aromatase Inhibitors. (2021) (5)
- Fragmentation of surgery and chemotherapy in the initial phase of ovarian cancer care and its association with overall survival. (2021) (5)
- Adjuvant treatment for elderly patients with early-stage lung cancer treated with limited resection. (2013) (5)
- Use of Bevacizumab for Elderly Patients With Stage IV Colon Cancer: Analysis of SEER-Medicare Data. (2019) (5)
- Regionalization of care for women with ovarian cancer. (2019) (5)
- Assessment of Electronic Alert to Reduce Overuse of Granulocyte Colony-Stimulating Factor in Patients Hospitalized for Febrile Neutropenia (2018) (5)
- Potential Consequences of Minimum-Volume Standards for Hospitals Treating Women With Ovarian Cancer. (2019) (5)
- Disparities in breast cancer care and research: report from a Breast Cancer Research Foundation sponsored workshop, 9–10 October 2014 (2015) (5)
- Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments (2021) (5)
- Use of fertility preservation services in female reproductive-aged cancer patients (2018) (5)
- Estimating global treatment toxicity burden from adverse‐event data (2018) (5)
- Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221) (2018) (5)
- Impact of estrogen monotherapy on survival in women with stage III-IV non-small cell lung cancer. (2019) (5)
- Integrating value of research into NCI Clinical Trials Cooperative Group research review and prioritization: A pilot study (2018) (5)
- A randomized phase II trial of fulvestrant with or without ribociclib after progression on aromatase inhibition plus cyclin-dependent kinase 4/6 inhibition in patients with unresectable or metastatic hormone receptor positive, HER2 negative breast cancer. (2017) (5)
- Socioeconomic deprivation and cancer outcomes in patients treated in clinical trials. (2019) (5)
- Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630 (2016) (5)
- Healthcare utilization and cost of care in elderly breast cancer patients enrolled in SWOG clinical trials (2020) (5)
- Geographic distribution and survival outcomes for rural cancer patients treated in clinical trials. (2018) (5)
- Abstract S5-06: Randomized, placebo-controlled trial of duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG S1202) (2017) (5)
- Omega-3 fatty acids for aromatase inhibitor–induced musculoskeletal symptoms in women with early-stage breast cancer (SWOG S0927). (2014) (5)
- SWOG S0715: Randomized placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy during adjuvant breast cancer therapy. (2012) (5)
- Effect of exercise on weight, body fat, and serum inflammatory biomarkers in breast cancer survivors with aromatase inhibitor arthralgias: The hormones and physical exercise (HOPE) study. (2014) (4)
- Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer (2022) (4)
- Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials. (2021) (4)
- Prospective Evaluation of Joint Symptoms in Postmenopausal Women Initiating Aromatase Inhibitors for Early Stage Breast Cancer. (2009) (4)
- A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer. (2020) (4)
- CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC). (2018) (4)
- Trends in Periodic Surveillance Testing for Early-Stage Uterine Cancer Survivors (2016) (4)
- Assessment of Regional Variability in COVID-19 Outcomes Among Patients With Cancer in the United States (2022) (4)
- Social and Racial Differences in Selection of Breast Cancer Adjuvant Chemotherapy Regimens (2008) (4)
- Trends in end-of-life care and health care spending in women with uterine cancer (2017) (4)
- Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update. (2022) (4)
- Challenges and opportunities to developing a frailty index using electronic health record data. (2021) (4)
- Combined dynamic and static optical tomography for prediction of treatment outcome in breast cancer patients (2015) (4)
- Predicting tumor response in breast cancer patients using diffuse optical tomography (2013) (4)
- Factors and Costs Associated With Delay in Treatment Initiation and Prolonged Length of Stay With Inpatient EPOCH Chemotherapy in Patients With Hematologic Malignancies (2017) (4)
- Using diffuse optical tomograpy to monitor tumor response to neoadjuvant chemotherapy in breast cancer patients (2013) (4)
- Osteoporosis in colorectal cancer survivors: analysis of the linkage between SWOG trial enrollees and Medicare claims (2019) (4)
- Off-label and approved use of bevacizumab in elderly patients with colon cancer. (2010) (4)
- Intraoperative Rupture of the Ovarian Capsule in Early-Stage Ovarian Cancer: A Meta-analysis. (2021) (4)
- Trends in the Use of Minimally Invasive Adnexal Surgery in the United States. (2021) (4)
- Abstract PR-05: Effects of presurgical administration of tea polyphenols in women with operable breast cancer (2010) (4)
- Effect of healthy diet and exercise on chemotherapy completion rate in women with breast cancer: The Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) study: Study protocol for a randomized clinical trial. (2021) (4)
- Prospective Study Evaluating Changes in Bone Quality in Premenopausal Women With Breast Cancer Undergoing Adjuvant Chemotherapy. (2019) (4)
- Coronavirus Spectrum Infections (COVID-19, MERS, SARS) in Cancer Patients: A Systematic Review of the Literature (2020) (4)
- Data Quality of Chemotherapy-Induced Nausea and Vomiting Documentation (2021) (4)
- Association Between Neighborhood Socioeconomic Inequality and Cervical Cancer Incidence Rates in New York City. (2021) (4)
- Dynamic Vascular Optical Tomographic Imaging for Peripheral Artery Disease and Breast Cancer (2019) (4)
- Phase II study of the farnesyl transferase inhibitor tipifarnib plus fulvestrant in postmenopausal patients with hormone receptor-positive breast cancer: New York Cancer Consortium Trial P6205 (2007) (4)
- Identifying modifiable and non-modifiable risk factors associated with prolonged length of stay after hysterectomy for uterine cancer. (2018) (3)
- Factors associated with non-adherence to lenalidomide in patients with multiple myeloma. (2018) (3)
- Adverse Health Effects of Intermittent vs Continuous Androgen Deprivation Therapy for Metastatic Prostate Cancer-Reply. (2016) (3)
- New and persistent controlled substance use among patients undergoing mastectomy and reconstructive surgery (2021) (3)
- Phase II Feasibility Study of a Weight Loss Intervention in Female Breast and Colorectal Cancer Survivors (SWOG S1008) (2018) (3)
- Cumulative incidence of financial hardship in metastatic colorectal cancer patients: Primary endpoint results for SWOG S1417CD. (2020) (3)
- Trends in venous thromboembolism prophylaxis in gynecologic surgery for benign and malignant indications (2020) (3)
- Symptom clusters in patients with advanced prostate cancer. (2015) (3)
- Phase I-II study of the histone deacetytase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer. (2014) (3)
- Use of fertility preservation services in male reproductive-aged cancer patients (2021) (3)
- The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials. (2017) (3)
- Off-label and compendia use of chemotherapy in patients with metastatic cancer. (2013) (3)
- Patterns of care and outcomes for women with uterine cancer and ovarian metastases (2017) (3)
- Changes in Diffuse Optical Tomography Images During Early Stages of Neoadjuvant Chemotherapy Correlate with Tumor Response in Different Breast Cancer Subtypes (2021) (3)
- Opioid use and misuse in children, adolescents, and young adults with cancer: a systematic review of the literature (2021) (3)
- Bosutinib and exemestane (EXE) versus EXE alone in postmenopausal (postm) women with hormone receptor-positive (HR+) HER2-negative (HER2-) advanced breast cancer (ABC). (2011) (3)
- Risk of cardiovascular disease in women with and without a history of breast cancer: The Pathways Heart Study. (2020) (3)
- Aromatase inhibitors, arthralgias, and exercise in breast cancer survivors. (2012) (3)
- 1571: Adjuvant Intravesical Therapy and Improved Survival Among Elderly Patients with Superficial Bladder Cancer (2007) (3)
- Impact of weight loss and exercise on VEGF levels in breast cancer survivors. (2016) (3)
- Comparative effectiveness of upfront treatment strategies for advanced-stage ovarian cancer (2013) (3)
- Safety and efficacy of neratinib (HKI-272) in combination with vinorelbine in patients with solid tumors. (2009) (3)
- High prevalence of vitamin D deficiency in premenopausal women with early-stage breast cancer. (2006) (3)
- Body mass index, lifestyle factors, and taxane-induced neuropathy in women with breast cancer: The Pathways study. (2016) (3)
- Minimally invasive surgery for suspected early‐stage ovarian cancer; a cost‐effectiveness study (2021) (3)
- Abstract OT1-4-03: Phase I study of erlotinib and metformin in triple negative breast cancer (2013) (3)
- Association of baseline cardiovascular risk factors and health care utilization and costs in elderly breast cancer patients enrolled in SWOG clinical trials. (2019) (3)
- Phase IB trial of ACY-1215 (Ricolinostat) combined with nab-paclitaxel in metastatic breast cancer. (2018) (2)
- Predictors of Interventional Treatment Use for Venous Thromboembolism in Cancer Patients (2016) (2)
- Long-term consequences of intermittent and continuous androgen deprivation in older patients with metastatic prostate cancer. (2015) (2)
- Association between insurance plan, prior authorization, and time to receipt of oral anticancer drugs. (2021) (2)
- Economic Evaluations in National Cancer Institute-Sponsored Network Cancer Clinical Trials. (2020) (2)
- Deviations from guideline-based therapy for febrile neutropenia in cancer patients. (2012) (2)
- Abstract GS1-08: CCTGMA.32, a phase III randomized double-blind placebo controlled adjuvant trial of metformin (MET) vs placebo (PLAC) in early breast cancer (BC): Results of the primary efficacy analysis (clinical trials.gov NCT01101438) (2022) (2)
- Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials (2021) (2)
- The effect of metformin on sex hormones in non-diabetic breast cancer patients in CCTG MA.32: A Phase III randomized adjuvant trial of metformin versus placebo in addition to standard therapy. (2019) (2)
- ASCO's Quality Care Symposium and the Evolving Science of Value-Based Care. (2020) (2)
- A comparison of nurses’ and physicians’ perception of cancer treatment burden based on reported adverse events (2019) (2)
- Measuring the Real Clinical Impact of Randomized Clinical Trials in Oncology-Reply: Beyond Citation Counts. (2016) (2)
- Using Delayed Toxicities to Re-evaluate Tolerability in Phase 2 Trials: A Case Example using Bortezomib (2017) (2)
- ‘Minority report’: how best to analyze clinical trial data to address disparities (2009) (2)
- A multicenter phase II study of docosahexaenoic acid (DHA) in patients (pts) with a history of breast cancer (BC), premalignant lesions, or benign breast disease. (2014) (2)
- Predictive model of aromatase inhibitor non-adherence using patient-reported outcomes in women with breast cancer (SWOG S1105). (2020) (2)
- Abstract 28: Phase I trial of combined temsirolimus, erlotinib, and cisplatin in advanced solid tumors. (2013) (2)
- Ethnic Neutropenia and Treatment Delay in African (2003) (2)
- Pregnancy despite ovarian insufficiency in a patient with breast cancer (2013) (2)
- Cumulative incidence of financial hardship in metastatic colorectal cancer (mCRC) patients (pts): Primary endpoint results for SWOG S1417CD. (2020) (2)
- Adherence to PARP inhibitor therapy among women with ovarian cancer. (2021) (2)
- Using publicly reported hospital data to predict obstetric quality (2017) (2)
- Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients (2016) (2)
- Abstract PD10-08: Baseline patient reported outcomes predict aromatase inhibitor adherence failure among women in enrolled in a randomized trial of text-messaging (2020) (2)
- High prevalence of vitamin D deficiency in a multi-ethnic cohort of premenopausal breast cancer patients (2008) (2)
- Factors Associated With Follow-Up Care Among Women With Early-Stage Breast Cancer. (2019) (2)
- The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention (2021) (2)
- Thoracoabdominal muscular enlargement in dermatomyositis: CT visualization. (2005) (2)
- Abstract P1-07-01: Safety of High-Dose Vitamin D Supplementation in Premenopausal Women at High Risk for Breast Cancer (2010) (2)
- Associations between acculturation, weight, diet quality, and physical activity among Latina breast cancer survivors: The ¡Mi Vida Saludable! study. (2022) (2)
- Randomized double-blind placebo-controlled biomarker modulation study of vitamin d in premenopausal women at high risk for breast cancer (SWOG S0812). (2018) (2)
- Relative importance of individual insurance status and hospital payer mix on survival for women with cervical cancer. (2022) (2)
- Chemotherapy Monitoring of Breast Cancer Patients with a Dual-Breast Dynamic Optical Tomography System (2014) (2)
- Trends in Use of Myomectomy for the Surgical Management of Uterine Leiomyomas in Perimenopausal and Postmenopausal Women. (2021) (2)
- Diffuse Optical Tomography Imaging System for Monitoring Breast Tumor Response to Neoadjuvant Chemotherapy (2012) (2)
- Opportunistic Salpingectomy at the Time of Laparoscopic Cholecystectomy for Ovarian Cancer Prevention (2022) (2)
- Mutational analysis of circulating tumor cells in breast cancer patients by targeted clonal sequencing. (2012) (2)
- Use of Conservative Therapies Before Hysterectomy for Uterine Leiomyomas (2023) (2)
- Neuronal Protection for Chemotherapy Neuropathy Prevention? (2019) (2)
- Survey of the prevalence and severity of sexual dysfunction in breast cancer patients (2008) (2)
- Incidence and Predictors of Diabetes Mellitus after a Diagnosis of Early-Stage Breast Cancer in the Elderly Using Real-World Data (2020) (2)
- Trends in ovarian conservation and association with survival in premenopausal patients with stage I leiomyosarcoma. (2021) (2)
- Measure for measure: the cost of improving quality. (2014) (2)
- Abstract PS3-10: Monitoring neoadjuvant chemotherapy using diffuse optical tomography breast imaging system (2021) (1)
- Room for improvement in breast cancer clinical trial design: taking advantage of the preoperative setting. (2013) (1)
- Diagnosis of leptomeningeal metastasis through identification of circulating tumor cells in cerebrospinal fluid using the TargetSelector™ assay (2021) (1)
- Design and accrual of S1417CD: Development of a prospective financial impact assessment tool in patients with metastatic colorectal cancer (mCRC). (2019) (1)
- Pathologic characteristics, patterns of care, and outcomes of Asian-Americans and Pacific islanders with uterine cancer. (2022) (1)
- Use and Misuse of Opioids After Gynecologic Surgical Procedures (2019) (1)
- Phase II feasibility study of a physical activity and dietary change weight loss intervention in a subset analysis of breast cancer survivors (SWOG S1008). (2015) (1)
- Social support at diagnosis and noninitiation, discontinuation, and nonadherence to adjuvant hormonal therapy in the Pathways Study. (2017) (1)
- Abstract 4344: Racial representativeness of cancer clinical trials sponsored by the National Cancer Institute compared to pharmaceutical companies (2020) (1)
- Cancer Antigen 15-3/Mucin 1 Levels in CCTG MA.32: A Breast Cancer Randomized Trial of Metformin vs Placebo (2021) (1)
- Toxicity after adjuvant therapy for stage III uterine cancer. (2020) (1)
- New and Persistent Sedative-Hypnotic Use after Adjuvant Chemotherapy for Breast Cancer. (2022) (1)
- Delay in receipt of newly prescribed oral anticancer drugs. (2019) (1)
- Robotic vs laparoscopic hysterectomy--reply. (2013) (1)
- Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk (2014) (1)
- Better Together: Clinical and Genomic Data to Inform Shared Decision Making. (2020) (1)
- A phase I trial of scutellaria barbata (BZL101) for metastatic breast cancer (2008) (1)
- 941 INTERMITTENT VS. CONTINUOUS ANDROGEN DEPRIVATION THERAPY AMONG ELDERLY PATIENTS WITH ADVANCED PROSTATE CANCER (2012) (1)
- A standardized workflow to improve the consent process among patients initiating an oral anticancer drug. (2019) (1)
- Do Surgeons or Does Hospital Economics Ultimately Decide Operative Approach?-Reply. (2016) (1)
- Phase I study of erlotinib and metformin in metastatic triple negative breast cancer (2020) (1)
- Barriers to participation in breast cancer trials (2007) (1)
- Comparative Effectiveness of Robotically Assisted Compared With Laparoscopic Adnexal Surgery for Benign Gynecologic Disease (2015) (1)
- Utility of preoperative breast MRI in patient selection for accelerated partial breast irradiation by different consensus guidelines (2017) (1)
- 5-month monitoring of tumor response in patients with breast cancer who undergo neoadjuvent therapy with diffuse optical tomography (2016) (1)
- Predictive markers of chemotherapy-induced menopause in premenopausal women under the age of 40 with breast cancer. (2009) (1)
- Comparative effectiveness of robotic gynecologic surgery. (2012) (1)
- Dissociation of mullerian inhibiting substance (MIS) and estradiol (E2) levels after chemotherapy in young women with breast cancer (2008) (1)
- Perioperative and persistent opioid utilization following pancreatectomy in the United States. (2021) (1)
- Effects of a Combined Physical Activity and Dietary Change Intervention on Weight Loss in Minority Breast Cancer Survivors. (2009) (1)
- Diffuse optical tomography breast imaging measurements are modifiable with pre-surgical targeted and endocrine therapies among women with early stage breast cancer (2021) (1)
- Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer Jennifer C. LivaudaisDawn L. HershmanLaurel HabelLawrence Kushi • Scarlett Lin GomezChristopher I. LiAlfred I. NeugutLouis Fehrenbacher • Beti ThompsonGloria D. Coronado (2012) (1)
- Comparative effectiveness of screening, surgery, and chemoprevention among BRCA1/2 mutation carriers. (2010) (1)
- Prospective evaluation of neurotoxicity in breast cancer patients treated with adjuvant paclitaxel (2008) (1)
- Dose-dependent pharmacokinetic (PK) interaction of pegylated liposomal doxorubicin (PLD) with escalating doses of veliparib in a phase I study. (2013) (1)
- Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline (2022) (1)
- Vitamin B12 (Vit B12) biochemical (BCH) deficiency (DEF) in non-diabetic breast cancer (BC) patients on NCIC CTG MA.32: A phase III randomized adjuvant BC trial comparing metformin (Met) to placebo (Pl). (2014) (1)
- Long-term outcomes of vaginal hysterectomy for endometrial cancer. (2021) (1)
- Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer (2022) (1)
- Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors (2021) (1)
- Containment Bag Use Among Women Who Undergo Hysterectomy With Laparoscopic Power Morcellation (2022) (1)
- Prevalence of HIV, hepatitis B virus (HBV), and hepatitis C virus (HCV) among newly diagnosed cancer patients treated in academic and community oncology practices: SWOG S1204. (2018) (1)
- A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxicities FACT-EGFRI 18 questionnaire: SWOG S1013 (2020) (1)
- Chemotherapy-related adverse events among breast cancer patients: A retrospective analysis of the SEER-Medicare database. (2006) (1)
- Using machine learning, general regression, and cox proportional hazards regression to predict the effectiveness of treatment in patients with breast cancer (2006) (1)
- Measurement and validation of frailty as a predictor of outcomes in women undergoing major gynecologic surgery (2015) (1)
- Heterogeneity of outcomes of endometrial cancer patients included in prospective clinical trials. (2022) (1)
- 156 NATIONWIDE PRACTICE PATTERNS FOR THE USE OF VENOUS THROMBOEMBOLISM PROPHYLAXIS AMONG MEN UNDERGOING RADICAL PROSTATECTOMY (2013) (1)
- Adoption of minimally invasive surgery after neoadjuvant chemotherapy in women with metastatic uterine cancer. (2021) (1)
- Abstract GS3-08: Persistent controlled substance use following mastectomy with reconstruction surgery (2021) (1)
- A randomized trial of a healthy lifestyle intervention versus usual care on chemotherapy and endocrine therapy adherence rate in women with breast cancer: The Lifestyle Exercise and Nutrition Early After Diagnosis (LEANER) Study. (2019) (1)
- Patient comorbid conditions and cancer clinical trial participation. (2018) (1)
- Abstract A48: Pitfalls of using breast magnetic resonance imaging (MRI) in an early-phase breast cancer chemoprevention trial of vitamin D among high-risk postmenopausal women (2011) (1)
- Abstract CN06-02: Phase IB randomized, double-blinded, placebo-controlled, dose escalation study of Polyphenon E in women with a history of hormone receptor-negative breast cancer (2011) (1)
- Dynamic diffuse optical tomography for assessing changes of breast tumors during neoadjuvant chemotherapy (2015) (1)
- Utilization and outcomes of adjuvant therapy for stage II and III uterine leiomyosarcoma. (2022) (1)
- History of Diabetes and Survival Outcome Among Participants 65 Years or Older in SWOG Clinical Trials. (2017) (1)
- Trends in Use and Outcomes of Women Undergoing Hysterectomy With Electric Power Morcellation (2016) (1)
- Phase I study of the PARP inhibitor ABT-888 (veliparib) and pegylated liposomal doxorubicin (PLD) in recurrent ovarian (ov) and breast (br) cancers (2012) (1)
- New persistent opioid use among adolescents and young adults with sarcoma (2022) (1)
- Cognitive Functioning and Health in Hispanic/Latina Breast Cancer Survivors (2021) (1)
- Cancer chemoprevention: how do we know what works? (2007) (1)
- Management of complications from estrogen deprivation in breast cancer patients (2009) (1)
- Early treatment window for predicting breast cancer response to neoadjuvant chemotherapy in the HR+/HER2- subgroup using diffuse optical tomography (2022) (1)
- Erratum to: The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study (2009) (1)
- Differences in global toxicity burden among patients and care providers during initial chemotherapy for breast cancer. (2017) (1)
- Dostarlimab for recurrent mismatch repair‐deficient endometrial cancer: A cost‐effectiveness study (2022) (1)
- Patterns of decision making about cancer clinical trial participation among the online cancer treatment community: A collaboration between SWOG and NexCura. (2012) (1)
- Use of Estrogen Therapy After Surgical Menopause in Women Who Are Premenopausal (2022) (1)
- “When offered to participate”: A systematic review and meta-analysis of patient agreement to participate in cancer clinical trials. (2020) (1)
- Relationship between physician characteristics and the use of newer chemotherapy for the treatment of colon cancer. (2011) (1)
- Design, data linkage, and implementation considerations in the first cooperative group led study assessing financial outcomes in cancer patients and their informal caregivers. (2020) (1)
- Chapter 8 – Adjuvant Therapy for Elderly Patients with Breast, Colon, and Lung Cancer (2012) (1)
- Patterns of cervical cancer screening among Medicaid beneficiaries (2021) (1)
- Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography (2021) (1)
- Abstract B02: ¡Cocinar Para Su Salud!: Long-term effects of a short-term culturally based dietary intervention among Hispanic breast cancer survivors (2013) (1)
- Baseline oxygen saturation comparison between pathologic complete responders and extensive residual cancer cases in response to neoadjuvant chemotherapy (2017) (0)
- Abstract P1-01-02: Early changes in diffuse optical tomography predicts pathologic complete response to neoadjuvant chemotherapy in triple-negative breast cancer (2020) (0)
- Factors associated with neurokinin-1 receptor antagonist use among commercially insured cancer patients receiving highly emetogenic chemotherapy. (2017) (0)
- Reply to S. Sukumar et al (2012) (0)
- Adverse Health Events Following Intermittent and Continuous Androgen Deprivation in Metastatic Prostate Cancer Patients (2016) (0)
- Current treatments, determinants of use, and survival for patients with hepatoma in the United States from 1998-2002. (2006) (0)
- In Reply. (2021) (0)
- Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study (2014) (0)
- Beyond patient-level barriers: Evaluation of rural residency and area-level deprivation and clinical trial (CT) participation. (2020) (0)
- Lymphedema after breast cancer in a prospective cohort study (2008) (0)
- How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? (2017) (0)
- Reply to S.A. Narod (2010) (0)
- Contributors (2019) (0)
- Abstract P1-10-07: A randomized, controlled, 2x2 factorial trial of a diet and physical activity intervention among Latina breast cancer survivors: ¡Mi Vida Saludable! study (2022) (0)
- Abstract PD8-07: Evaluation of Tucatinib + (Paclitaxel + Pertuzumab + Trastuzumab) followed by AC in high-risk HER2 positive (HER2+) stage II/III breast cancer: Results from the I-SPY 2 TRIAL (2022) (0)
- V ariations i n t he U se o f C hemotherapy f or E lderly P atients With A dvanced O varian C ancer: A P opulation-Based S tudy (2002) (0)
- Abstract PD6-04: PD6-04 Baseline Insurance and Unplanned Emergency Room Use and Hospitalizations Among Elderly Breast Cancer Patients Participating in Clinical Trials (2023) (0)
- Randomized Trial Of Exercise On Body Composition In Breast Cancer Survivors Taking Aromatase Inhibitors: 1285 Board #6 June 2, 8: 00 AM - 10: 00 AM. (2016) (0)
- Comparative effectiveness of minimally invasive radical hysterectomy for cervical cancer (2012) (0)
- Abstract 2767: Consistency of standing orders for primary prophylactic CSF within a national network of community oncology practices: SWOG intergroup trial S1415CD (2017) (0)
- The association of patient fatigue and outcomes in advanced cancer: An analysis of four SWOG treatment trials. (2020) (0)
- Trends and safety of image-guided percutaneous pleural biopsies in cancer patients. (2014) (0)
- Patterns of use and outcomes of adjuvant bevacizumab therapy prior to regulatory approval in women with newly diagnosed ovarian cancer (2022) (0)
- Abstract 5489: A genome-wide association study identifies novel loci associated with taxane-related sensory neuropathy in breast cancer patients enrolled in a cooperative group clinical trial (SWOG S0221) (2015) (0)
- Randomized trial of diet and exercise on chemotherapy completion in women with breast cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) study. (2022) (0)
- The increasing interest and biologic rationale justify continued research in the area of cancer prevention and treatment. Ongoing clinicaltrialsmayhelpclarifywhetherchangingawoman'svitaminD status will alter her risk of breast cancer or, for those who develop breast cancer, whether it will alter the (2009) (0)
- Abstract GS5-04: Identification of symptoms that are associated with irAEs in the I-SPY clinical trial (2023) (0)
- Abstract A73: Evaluating tissue biomarker effects of an oral green tea extract, polyphenon E, using reverse phase protein array in women with operable breast cancer (2012) (0)
- Prolonged radiation duration in women with cervical cancer: A population-based analysis of associated factors and impact on survival. (2014) (0)
- Abstract OT3-19-02: Introducing an electronic platform to collect patient reported outcomes in the I-SPY 2 trial, a neoadjuvant clinical trial (2020) (0)
- Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer (2023) (0)
- Abstract P4-12-02: Improving patient-reported outcome data capture for clinical research: ePRO in ISPY 2, a phase 2 breast cancer study (2022) (0)
- Effect of metformin versus placebo on metabolic factors in the MA.32 randomized breast cancer trial (2021) (0)
- Abstract PD5-01: Cardiovascular disease risk of breast cancer therapies: The pathways heart study (2022) (0)
- High- versus low-dose rate brachytherapy for locally advanced cervical cancer (2015) (0)
- Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design (2017) (0)
- Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016 (2022) (0)
- Patients enrolled in clinical trials with Medicaid or no insurance and overall survival benefits from new interventions. (2019) (0)
- Reply to R.T. Chlebowski (2009) (0)
- Effects of a Guideline-Informed Clinical Decision Support System Intervention to Improve Colony-Stimulating Factor Prescribing (2022) (0)
- Performance of hysterectomy by very low-volume surgeons and their outcomes (2018) (0)
- Impact of Discoordinated Care on Healthcare Utilization and Survival in Stage IV Non-Small Cell Lung Cancer Patients (2021) (0)
- Inequity in location and quality of death of advanced cancer patients by immigrant status. (2021) (0)
- Abstract P1-11-04: Association between body mass index (BMI) and response to duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) (2019) (0)
- racial Disparities in P osttraumatic Stress After Diagnosis of localiz ed Breast cancer: t he BQU Al Study (2013) (0)
- Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin versus placebo in hormone receptor–positive early-stage breast cancer (CCTG MA32). (2022) (0)
- Temporal Trends in Cervical Cancer Screening Practices and Associated Downstream Abnormalities and Procedures Among Women With Insurance in the United States (2022) (0)
- A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia (2022) (0)
- Abstract IA28: Disparities in cardiovascular disease incidence in breast cancer survivors (2020) (0)
- Erratum. Clinical Practice Guidelines on the Use of Integrative Therapies as Supportive Care in Patients Treated for Breast Cancer. (2015) (0)
- Racial and ethnic disparities in cancer treatment (2007) (0)
- Randomized sham controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy. (2015) (0)
- A pragmatic cluster-randomized trial of a standing physician order entry intervention for colony stimulating factor use among patients at intermediate risk for febrile neutropenia (SWOG S1415CD). (2022) (0)
- Impact of a hospital specialty pharmacy in partnership with a free-standing care coordination organization on time to delivery and receipt of oral anticancer drugs. (2021) (0)
- Abstract P1-11-09: Early discontinuation of adjuvant chemotherapy in women with early stage breast cancer: The BQUAL study (2015) (0)
- Title Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer : SWOG S 9630 (2016) (0)
- Ethnicity, Age, and Employment Associated with Persistent Symptoms in Breast Cancer Survivors. (2009) (0)
- Associations between self-reported diet during treatment and chemotherapy-induced peripheral neuropathy in a cooperative group trial (S0221) (2018) (0)
- Abstract OT1-1-08: Master regulator (MR)-directed therapy in residual breast cancer patient derived xenografts (PDXs) (2015) (0)
- Author reply (0)
- An RNA-Based Precision Oncology Platform for Patient-Therapy Alignment in a Diverse Set of Treatment Resistant Malignancies (2022) (0)
- In Reply. (2015) (0)
- Abstract P1-19-32: Phase I/II trial of ruxolitinib in combination with trastuzumab in HER2+ metastatic breast cancer (MBC) (2020) (0)
- The influence of patient engagement on the design and implementation of a clinical trial to improve cancer care delivery. (2018) (0)
- Reply to T.P. Houston et al. (2018) (0)
- Abstract P4-11-33: Continuous glucose monitoring and hyperglycemia during chemotherapy for early-stage breast cancer (2022) (0)
- Risk Prediction of Hepatitis B or C or HIV Among Newly Diagnosed Cancer Patients. (2023) (0)
- Abstract C28: Effects of vitamin D supplementation on breast imaging and blood-based biomarkers of breast cancer risk (2013) (0)
- Neoadjuvent therapy monitoring in breast cancer patients with diffuse optical tomography (2018) (0)
- Can order entry systems improve oncology practice? The TrACER Experience. (2022) (0)
- Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms (2021) (0)
- Abstract P1-19-27: Phase IB trial of ACY-1215 (ricolinostat) combined with nab-paclitaxel in metastatic breast cancer (MBC) (2020) (0)
- Influence of hospital characteristics on immediate breast reconstruction following mastectomy. (2012) (0)
- Abstract 2162: Prior bone health history in breast cancer patients on aromatase inhibitors (2014) (0)
- Implementation of Systematic Financial Screening in an Outpatient Breast Oncology Setting. (2023) (0)
- Population-level survival trends for uterine cancer (2015) (0)
- Anthracycline Cardiotoxicity After Breast Cancer Treatment March (2017) (0)
- Uptake and patterns of use of gemcitabine for stage IV pancreatic cancer (2013) (0)
- Factors associated with follow-up physician visits among women with early stage breast cancer. (2018) (0)
- Use of Herpes Zoster Prophylaxis in Myeloma Patients Treated with Proteasome Inhibitors (2017) (0)
- Implementation of EHR medication-adherence screening tool in breast cancer clinic. (2022) (0)
- The COVID-19 pandemic impact on breast cancer care delivery at an academic center in New York City. (2020) (0)
- Safety of progestational therapy in young women with endometrial cancer (2017) (0)
- Diagnosis of leptomeningeal metastasis in women with breast cancer through identification of tumor cells in cerebrospinal fluid using the CNSide™ assay. (2021) (0)
- Reply to C.A. Hudis et al (2012) (0)
- Issue information (2014) (0)
- Abstract P3-07-22: Presurgical Trial of Metformin plus Atorvastatin in Women with Operable Breast Cancer (2023) (0)
- Abstract A44: Association between BMI at treatment initiation and cancer survival across multiple SWOG trials (2015) (0)
- Successes and challenges of implementing a cancer care delivery intervention in community oncology practices: lessons learned from SWOG S1415CD (2022) (0)
- Implementing an EHR guideline–based intervention in paper ordering systems. (2018) (0)
- Impact of value of research analyses on SWOG’s clinical trial capsule scoring. (2017) (0)
- Evaluation of the protective effects of zoledronic acid on bone mass in premenopausal women undergoing adjuvant chemotherapy following treatment discontinuation. (2009) (0)
- Abstract 16083: Risk of Preserved versus Reduced Ejection Fraction in Women With and Without History of Breast Cancer: The Pathways Heart Study (2020) (0)
- Abstract WS1-2: How to measure and improve drug adherence in clinical trials (2023) (0)
- A Structured Approach to Prioritizing Cancer Research Using Stakeholders and Value of Information (2018) (0)
- Diffusion of abiraterone use in prostate cancer patients. (2016) (0)
- Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer (2022) (0)
- Delays in care following a COVID diagnosis. (2022) (0)
- Abstract P4-11-04: A randomized adaptive sequential selection trial of cryotherapy, compression therapy, and placebo to prevent taxane inducted peripheral neuropathy in patients with breast cancer (2022) (0)
- Comparison of physicians, nurses' and patients' assessment of overall symptom burden. (2016) (0)
- Abstract A034: Baseline characteristics of participants enrolled in a randomized controlled trial of a diet and physical activity intervention among Hispanic/Latina breast cancer survivors (in progress) (2020) (0)
- Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast Cancer (2023) (0)
- Impact of Socioeconomic Status on Extent of Lymph Node Dissection for Colon Cancer Epidemiology,Biomarkers&Prevention (2010) (0)
- Correlation between risk benefit index and uptake of breast cancer chemoprevention. (2014) (0)
- Association between oncology clinical pathway utilization and quality and cost outcomes in patients with metastatic solid tumors. (2022) (0)
- Incidence and Predictors of Bowel Obstruction in Elderly PatientsWith Stage IV Colon Cancer A Population-Based Cohort Study (2013) (0)
- Patterns of perioperative use and persistent use of opioids after gynecologic surgery (2019) (0)
- Reply to L. Gianni et al. (2015) (0)
- Racial/EthnicandSocioeconomicDifferences inShort-TermBreastCancerSurvivalAmong WomeninanIntegratedHealthSystem (2015) (0)
- Factors associated with failure to receive oral anticancer drugs. (2021) (0)
- Phase I randomized, placebo-controlled, cross-over dose-finding pharmacokinetic study of Coenzyme Q10 during one cycle of doxorubicin treatment for breast cancer. (2021) (0)
- Abstract P4-11-16: Feasibility and patient satisfaction with a smartphone application to improve medication adherence among patients with breast cancer (2022) (0)
- Patterns of use and outcomes of adjuvant chemotherapy and radiation for early-stage uterine papillary serous carcinoma (2017) (0)
- MA22.02 The Impact of Patient Engagement on Study Design and Patient Recruitment in a Pragmatic Trial to Improve Cancer Care Delivery (2019) (0)
- Abstract P4-14-03: Household net worth is associated with racial disparities in hormonal therapy adherence among women with early stage breast cancer (2015) (0)
- Abstract PD5-08: New and persistent sedative hypnotic use after adjuvant chemotherapy for breast cancer (2022) (0)
- A novel analysis of data from the PALOMA-3 trial confirms the efficacy of palbociclib and provides an option for efficacy assessments that could accelerate drug approvals. (2022) (0)
- From A to Xeloda: Practical considerations for implementing a chemotherapy regimen ordering system intervention. (2018) (0)
- Abstract P3-02-04: Prediction of breast cancer response to neoadjuvant chemotherapy in different biological breast cancer subtypes using diffuse optical tomography (2022) (0)
- Ethnic differences in tumor proliferation in women with early-stage breast cancer. (2013) (0)
- Value of Anti-Cancer Drugs in SWOG Phase III Clinical Trials: Evidence from Multiple Evaluation Mechanisms (2018) (0)
- Comorbidities and risk of chemotherapy-induced peripheral neuropathy among participants in SWOG clinical trials. (2016) (0)
- 31/#204 Cost-effectiveness of hysterectomy at the time of risk-reducing bilateral salpingooophorectomy for patients with BRCA1 mutations (2022) (0)
- Looking beyond the first cycle in phase I cancer clinical trials. (2014) (0)
- NCI Breast Cancer Steering Committee Working Group (WG) report on meaningful and appropriate endpoints for clinical trials (CT) in metastatic breast cancer (MBC). (2017) (0)
- Socioeconomic deprivation and patient-reported outcomes in symptom management trials for patients with breast cancer. (2022) (0)
- Abstract P5-01-05: Early optical tomography changes correlate with residual cancer burden scores in women receiving neoadjuvant chemotherapy (2015) (0)
- Use of high-intensity surveillance in patients following a diagnosis of stage I-II non-small cell lung cancer. (2013) (0)
- Surveillance testing in women following a diagnosis of early-stage endometrial cancer (2014) (0)
- Incorrect Affiliations and Updated Supplement. (2016) (0)
- Comparison of attitudes and beliefs about cancer clinical trial enrollment between physicians, research staff, and cancer patients. (2019) (0)
- Family history of breast or ovarian cancer modifies the risk of secondary leukemia after breast cancer: Results from a population-based study (2008) (0)
- Identifying predictors of taxane-induced peripheral neuropathy using shotgun proteomics technology. (2015) (0)
- Acknowledgment of Reviewers 2015 (2015) (0)
- Abstract OT2-6-06: Pre-surgical “window of opportunity” trial of metformin and atorvastatin in newly diagnosed operable breast cancer (2013) (0)
- Association between immigrant status and advanced cancer patients' location and quality of death (2022) (0)
- Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A. (2022) (0)
- Preference-weighted quality of life: Findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT). (2021) (0)
- OA07.06 Patient Knowledge and Expectations Related to Return of Genomic Results in the Lung-MAP (SWOG 1400) Biomarker-Driven Clinical Trial (2019) (0)
- Abstract 4127: A prospective study of breast cancer prognosis in Kaiser Permanente Northern California: Cohort description and initial findings from the Pathways Study (2014) (0)
- Abstract PR01: Knowledge, attitudes, and uptake of breast cancer chemoprevention in a multi-ethnic cohort of high-risk women (2015) (0)
- Diagnosis of leptomeningeal metastasis (LM) through identification of circulating tumor cells (CTCs) in cerebrospinal fluid (CSF). (2020) (0)
- Usage of Oregon's Death With Dignity Act (DWDA). (2016) (0)
- Total hemoglobin changes in the breast tumors volume of patients undergoing neoadjuvant chemotherapy: a longitudinal analysis (2021) (0)
- 58 – Effects of Hormone Deprivation in Survivors of Breast and Prostate Cancer (2004) (0)
- Efficacy of a password‐protected, pill‐dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery (2022) (0)
- Patterns and predictors of chemotherapy and trastuzumab use for early-stage breast cancer in Kaiser Permanente Northern California, 2004-2007. (2012) (0)
- Abstract PD8-10: Identifying racial and ethnic disparities in psychosocial care among adults with metastatic breast cancer (mBC): A retrospective analysis across six New York health systems (2023) (0)
- Prediction of pathologic complete response in breast cancer neoadjuvant chemotherapy based on pretreatment data obtained with dynamic diffuse optical tomography (2022) (0)
- Abstract PD12-08: PD12-08 Randomized trial of exercise and nutrition on pathological complete response among women with breast cancer receiving neoadjuvant chemotherapy: the Lifestyle, Exercise and Nutrition Early after Diagnosis (LEANer) Study (2023) (0)
- Title Methods to Standardize a Multicenter Acupuncture Trial Protocol to Reduce Aromatase Inhibitor-related Joint Symptoms in Breast Cancer Patients Permalink (0)
- Prescription of hormone replacement therapy among cervical cancer patients with treatment-induced premature menopause (2022) (0)
- Trends inMedical Aid in Dying in Oregon andWashington (2019) (0)
- Survival outcomes by insurance status for patients with cancer ages 18-64 and 65 or older treated in clinical trials. (2022) (0)
- Efficacy of a password-protected pill-dispensing device to enhance disposal of unused opioids after cancer surgery. (2021) (0)
- Abstract P5-15-03: Baseline joint pain predicts severity of subsequent joint symptoms in women initiating aromatase inhibitors for early stage breast cancer (2015) (0)
- Racial and Ethnic Disparity in Preference-Weighted Quality of Life: Findings from the Selenium and Vitamin E Cancer Prevention Trial. (2023) (0)
- Abstract SY43-03: Sex differences in severe adverse events in patients receiving immunotherapy, targeted therapy, or chemotherapy in Cancer clinical trials: An evidentiary perspective (2023) (0)
- Prevalence of CAM in a cohort of breast cancer patients and controls. (2004) (0)
- P2-10-09: Detecting Breast Cancer with Dynamic Diffuse Optical Tomographic Imaging. (2011) (0)
- Intervention non-adherence in a pragmatic randomized trial of a standardized order entry for colony stimulating factor prescribing. (2022) (0)
- Hypertension and use of bevacizumab among patients treated in community settings. (2019) (0)
- BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. (2017) (0)
- Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer (2010) (0)
- Use of nonclinical staff to coordinate oral anticancer drug prescriptions. (2019) (0)
- Patient profile, patterns of care, and mortality among Asian and white women with uterine cancer (2018) (0)
- Management of menopausal symptoms in breast cancer survivors (2014) (0)
- Trends in obesity among patients registered to SWOG cancer clinical treatment trials. (2020) (0)
- Antiviral therapy use and related outcomes in patients with cancer and viral infections: results from SWOG S1204 (2022) (0)
- The Use of Superlatives in Cancer Research (2016) (0)
- Use of whole pelvic radiotherapy for high-intermediate risk endometrial cancer (2016) (0)
- Opioid prescribing practices in adolescent and young adults with sarcomas. (2020) (0)
- Utilization and effectiveness of extended-duration thromboprophylaxis after high-risk abdominopelvic cancer surgery. (2016) (0)
- Patient Knowledge and Expectations About Return of Genomic Results in a Biomarker-Driven Master Protocol Trial (SWOG S1400GEN). (2021) (0)
- Use of Electric PowerMorcellation and Prevalence of Underlying Cancer inWomenWhoUndergoMyomectomy (2015) (0)
- Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients (2020) (0)
- A phase I-II study of tipifarnib plus weekly paclitaxel (P) followed by dose-dense doxorubicin/cyclophosphamide (AC) in stage IIb-IIIc breast cancer (BC). (2013) (0)
- Total hemoglobin reduction in the tumor volume correlates with response to breast cancer neoadjuvant chemotherapy within two weeks of treatment (2019) (0)
- Phase IB randomized, double-blinded, placebo-controlled, dose-escalation study of polyphenon E in women with a history of hormone receptor-negative breast cancer. (2010) (0)
- Onset of cardiovascular disease risk factors in women with and without a history of breast cancer: The Pathways Heart Study. (2020) (0)
- Systemic Progestins and Progestin-Releasing Intrauterine Device Therapy for Premenopausal Patients With Endometrial Intraepithelial Neoplasia (2023) (0)
- Reply to F. Dayyani et al. (2016) (0)
- Use of colony stimulating factors (CSF) for primary prophylaxis of chemotherapy-induced neutropenia in community oncology practices to reduce risk of febrile neutropenia (FN) (2007) (0)
- The Economic Burden of Illness in Pediatric Acute Lymphoblastic Leukemia (ALL) Patients from a Commercial and Medicaid Insurance Perspective (2021) (0)
- The Importance of Patient-Reported Outcomes in Pragmatic Clinical Trials. (2023) (0)
- Trends in Human Papillomavirus Vaccination Among Women 27-45 years of age from 2017-2019 (2021) (0)
- Adherence to clinical practice guidelines for the prevention of acute chemotherapy-induced nausea and vomiting in children, adolescents, and young adults with cancer receiving their first cycle of highly emetogenic chemotherapy. (2019) (0)
- Relationship between surgical oncologic outcomes and publically reported hospital quality measures. (2014) (0)
- Omega-3 fatty acid use for obese breast cancer patients with aromatase inhibitor-related arthralgia (SWOG S0927). (2018) (0)
- - Session 1 : May 24 , 1 : 45 pm Altered Excitatory to Inhibitory Neurochemical Ratio in the Left Dorsolateral Prefrontal Cortex is Associated with Pain and Resting-State Functional Connectivity in Fibromyalgia Syndrome (2021) (0)
- Patterns of osteoporosis (OP) in survivors of colorectal cancer (CRC) enrolled on SWOG trials. (2017) (0)
- Comparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor–Related Joint Pain (2022) (0)
- Abstract A140: Factors associated with receipt of guideline-concordant treatment among Medicaid enrollees with breast and colorectal cancer (2020) (0)
- Feasibility of a digital medicine program in optimizing opioid pain control in cancer patients (SWOG S1916). (2020) (0)
- Prospective Evaluation of Neurotoxicity in Breast Cancer Patients Treated with Adjuvant Paclitaxel. (2009) (0)
- Pretreatment Prediction of Neoadjuvant Chemotherapy Response in HER-2 Positive Breast Cancer Patients Using Diffuse Optical Tomography Imaging (2020) (0)
- Abstract OT1-1-09: Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer (2013) (0)
- Patient factors associated with time to medication receipt of oral anti-cancer drugs. (2021) (0)
- Serum tumor marker utilization in patients with advanced solid tumors. (2015) (0)
- Racial disparities in lymph node dissection for colon cancer (2007) (0)
- Abstract B04: Development and comparison of 12-week and 4-week dietary interventions among Hispanic breast cancer survivors (2014) (0)
- Reasons for declining a pharmacist-led telehealth study among oncology patients initiating oral anti-cancer drugs. (2022) (0)
- Reexamining Social Determinants of Health Data Collection in the COVID-19 Era. (2022) (0)
- Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG). (2023) (0)
- Abstract P5-13-01: Uptake of breast cancer chemoprevention among high-risk women and those with ductal carcinoma in situ. (2013) (0)
- Long-term results from a randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in early stage breast cancer (S1200). (2021) (0)
- Abstract 4681: Effect of physician recommendation on multivitamin and antioxidant supplement use during chemotherapy in an adjuvant trial for breast cancer (SWOG S0221) (2011) (0)
- Optimizing the implementation of systematic financial screening. (2022) (0)
- Abstract 1266: Racial differences in the association of cruciferous vegetable intake with breast cancer hormone receptor status and tumor subtype (2014) (0)
- Hospitalization burden and end-of-life (EOL) care in elderly patients with glioblastoma (GBM). (2021) (0)
- Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-l-carnitine (SWOG S0715). (2017) (0)
- An evaluation of stakeholder engagement in comparative effectiveness research: lessons learned from SWOG S1415CD (2022) (0)
- Effects of neoadjuvant chemotherapy on the contralateral non-tumor-bearing breast assessed by diffuse optical tomography (2021) (0)
- Financial distress, health literacy, numeracy, and treatment receipt by race/ethnicity amongst breast cancer survivors. (2022) (0)
- Diffuse Optical Tomography Imaging of the Hemodynamic Response to a Breath Hold for Use in Breast Cancer Detection (2012) (0)
- Is Family History Associated With Improved Survival in Patients With Gastric Cancer (2012) (0)
- Factors Associated With Patients Not Receiving Oral Anticancer Drugs (2022) (0)
- Reply to A. Kolacevski et al. (2015) (0)
- Abstract PD12-03: Predictors of pain reduction in trials of interventions for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) (2021) (0)
- Abstract P5-07-03: The Association Between Symptom Severity and Physical Function among Participants in I-SPY2 (2023) (0)
- enceisacomplexissueandisnotdirectlyproportionaltothebenefitof themedication.Additionalresearchisneededtobetterunderstandthe factors that contribute to nonadherence to hormonal therapy as well as to other oral cancer treatments. (2010) (0)
- Comparing Ways to Improve Prescribing of Colony-Stimulating Factor in Cancer Treatment -- The TrACER Study (2022) (0)
- Acupuncture and Moxibustion for Side Effects of Chemotherapy in Cancer Patients (2012) (0)
- Abdominal vs Minimally Invasive Hysterectomy-Reply. (2016) (0)
- Abstract 5303: Cardiovascular disease risk associated with breast cancer chemotherapy drugs: The Pathways Heart Study (2022) (0)
- Variants in the BRCA1/Fanconi-Anemia Repair Pathway and Taxane-Induced Neuropathy in SWOG S0221. (2009) (0)
- Evaluation of a pharmacist-led video consultation to identify drug interactions among patients initiating oral anticancer drugs. (2022) (0)
- The Risk of Hepatocellular Carcinoma in Patients with Previous Malignancy (2008) (0)
- Developing a Diet and Physical Activity Intervention for Hispanic/Latina Breast Cancer Survivors (2022) (0)
- Integration of germline multigene panel testing into breast and gynecologic oncology clinics. (2021) (0)
- Abstract B65: Biomarker effects of an oral green tea extract, Polyphenon E, in women with a history of hormone receptor-negative breast cancer (2012) (0)
- Abstract 4482: Effects of lifestyle modification on global DNA methylation in minority breast cancer survivors (2012) (0)
- Disparities in cervical cancer incidence and neighborhood socioeconomic inequality in New York City (2021) (0)
- Monitoring total hemoglobin concentration changes across neoadjuvant chemotherapy in PgR-positive and PgR-negative breast cancer with diffuse optical tomography (2019) (0)
- Impact of clinic characteristics on the adoption of a guideline-based standing order algorithm and patient accrual in the pragmatic cluster-randomized trial SWOG S1415CD (NCT02728596). (2018) (0)
- ALTERNATIVE AND COMPLEMENTARY THERAPIES (2003) (0)
- Abstract PD8-06: Incidence of Acute and Persistent Clinically Meaningful Chemotherapy Induced Peripheral Neuropathy in Patients with Early-Stage Breast Cancer Receiving Taxane Therapy: SWOG S1714 (NCT# 03939481) (2023) (0)
- Medical and Surgical Retreatment for Uterine Leiomyoma After Myomectomy. (2023) (0)
- Abstract P1-01-08: Changes in breast density with mammography and breast MRI among high-risk postmenopausal women (2015) (0)
- Supplemental antioxidant intake and plasma protein carbonyl concentrations in the Long Island Breast Cancer Study Project (2007) (0)
- Abstract PD5-03: Development of cardiometabolic risk factors following endocrine therapy: The pathways heart study (2022) (0)
- Abstract PD6-06: PD6-06 Racial and ethnic disparities with influenza vaccine use in long-term survivors of metastatic breast cancer (2023) (0)
- The influence of hospital and surgeon factors on the prevalence of axillary evaluation in ductal carcinoma in situ. (2015) (0)
- Complementary and alternative medicine use and hormonal therapy initiation in women with hormone receptor-positive breast cancer: The BQUAL study. (2017) (0)
- Association Between Geographic Access and Receipt of Radiation Therapy (2015) (0)
- Predictors of compliance with payer-led oncology clinical pathways. (2022) (0)
- Abstract P6-12-07: Discordance in cyclin D1 changes after metformin exposure by different protein expression methods: Results from a "Window of Opportunity" trial (2015) (0)
- HMGA2 and its role in clinical response to treatment in patients with locally advanced breast cancer (2007) (0)
- Differences in clinician and patient assessment of baseline neuropathy in patients receiving taxane-based chemotherapy enrolled to SWOG S1714 (NCT# 03939481). (2022) (0)
- Researcher experience and comfort with telemedicine and remote patient monitoring in cancer treatment trials. (2022) (0)
- Preferences for breast cancer prevention among BRCA mutation carriers (2016) (0)
- Abstract ES8-3: Everything Comes at a Price - Toxicity, Cost and Adherence to Endocrine Therapy (2020) (0)
- OP-JNCI190013 531..537 (2019) (0)
- Evaluating Effects of an Oral Green Tea Extract, Polyphenon E, on Tissue Biomarkers, Using Reverse Phase Protein Array in Women with Operable Breast Cancer (2015) (0)
- Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer (2017) (0)
- The impact of NCI-sponsored network group clinical trials on guideline care and new drug indications. (2019) (0)
- OT2-07-02: SWOG S0927: A Randomized Double Blind Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor (AI)-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer. (2011) (0)
- Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma (2023) (0)
- Breast cancer knowledge and understanding treatment rationales among diverse breast cancer survivors (2022) (0)
- Comparative effectiveness of cancer control and survival after robotic assisted versus open radical prostatectomy (2016) (0)
- Understanding efficiency of chemotherapy delivery for planned chemotherapy admission at Columbia University Medical Center. (2016) (0)
- Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer Drugs (2022) (0)
- Abstract 3413: Supplement use and chemotherapy-induced peripheral neuropathy in breast cancer patients treated on SWOG study S0221 (2016) (0)
- Uptake of bevacizumab for the treatment of colon cancer. (2011) (0)
- Abstract OT1-15-01: SWOG 1904: Cluster-randomized controlled trial of patient and provider decision support to increase chemoprevention informed choice among women with atypical hyperplasia or lobular carcinoma in situ (MiCHOICE) (2023) (0)
- Optical tomographic imaging of the hemodynamic response to a breath hold in breast cancer patients (2011) (0)
- Working Hand in Glove to Prevent Chemotherapy-Induced Peripheral Neuropathy (2018) (0)
- Incorporating systematic financial screening into the electronic health record. (2021) (0)
- Secular trends in relative survival for ovarian cancer (2015) (0)
- 938 PATTERNS OF CARE IN THE USE OF PALLIATIVE THERAPY FOR URETERAL OBSTRUCTION AMONG ELDERLY PATIENTS WITH ADVANCED PROSTATE CANCER (2012) (0)
- Factors associated with over and underuse of response evaluation in elderly myeloma patients. (2019) (0)
- Erratum to: Barriers and Facilitators to Recruitment to a Culturally Based Dietary Intervention Among Urban Hispanic Breast Cancer Survivors (2015) (0)
- A transcriptome-based precision oncology platform for patient-therapy alignment in a diverse set of treatment resistant malignancies. (2023) (0)
- OT3-01-13: Phase One Trial of Combined Temsirolimus, Erlotinib, and Cisplatin in Advanced Solid Tumors. (2011) (0)
- In reply. (2013) (0)
This paper list is powered by the following services:
Other Resources About Dawn L. Hershman
What Schools Are Affiliated With Dawn L. Hershman?
Dawn L. Hershman is affiliated with the following schools:
